Visiopharm
About Visiopharm
Visiopharm is a leading provider of AI-driven precision pathology software, catering to both research and diagnostic applications. For physicians, Visiopharm offers advanced tools that transform pathology through image analysis, aiming to enhance precision and productivity in pathology labs. The company has developed nine diagnostic algorithms cleared under IVDR for EU and UK customers, which provide diagnostic decision support and can be seamlessly integrated into existing lab workflows. These applications are designed to deliver rapid, quantitative biomarker analysis with enhanced precision and efficiency, offering comprehensive insights into histopathology, drug target engagement, and pharmacodynamics.
In the realm of diagnostics, Visiopharm’s software, such as Oncotopix, utilizes virtual double staining and multiplexed biomarker tissue arrays for cancer diagnostics. The company’s AI algorithms and deep learning platform are crucial for improving imaging solutions for diagnostic approaches and decision support. Visiopharm’s commitment to advancing precision medicine is evident in its focus on providing reliable data that moves research forward, supporting drug discovery and development, spatial biology, and clinical research. Their solutions have been featured in over 3,500 scientific publications, underscoring their scientific advancement and impact in the field.
Focus Areas
Business Intelligence
| Key Investors | ATP, Danish Growth Fund (Vækstfonden), C. L. David Foundation and Collection, Northcap Venture Partners, BankInvest Group, EW Healthcare Partners |
| Partnerships | UMCG (University Medical Center Groningen), Molecular Instruments, Boston Cell Standards, Philips, Sectra, Hamamatsu, Indica Labs, Stratipath |
| Acquisitions | Digital Pathology Consultants (acquired by Visiopharm in 2010), Visiopharm acquired by Grundium (May 2026) |
| Technology | AI-driven image analysis software, deep learning, cloud-native (implied by integration capabilities), App Centre for ready-to-use AI-based apps, integrated with digital slide scanners |
| FDA Clearances | unknown cleared products (estimated) |
What Physicians Need to Know
For physicians, Visiopharm's solutions offer objective decision support for clinical biomarker scoring, improving diagnostic accuracy and workflow efficiency. Their AI-driven applications, such as the Metastasis Detection APP, can significantly reduce the time spent on manual assessment and increase the sensitivity of metastasis detection. The software is designed for a 'zero-click' workflow, minimizing manual interaction and providing results ready for review. The platform also helps standardize tissue-based patient stratification for clinical trials, addressing inconsistencies that can arise from variations in biomarker staining and evaluation across different labs. With their recent acquisition by Grundium, the combined platform offers an accessible end-to-end solution, integrating digital slide scanning with AI-driven software, which can lead to more efficient and scalable digital pathology.
Visiopharm's software is designed for seamless integration with existing lab infrastructure, including LIS/LIMS, IMS, PACS, and VNA systems. They are compatible with various image file formats from major slide scanners. This allows for a smooth transition to digital pathology and enhances overall productivity by incorporating image analysis results into existing laboratory information systems.
What the Web Says
Visiopharm generally receives positive to mixed reviews, particularly for its AI-driven precision pathology software which is praised for its advanced features and utility in research and clinical settings. However, some users note a steep learning curve and occasional performance issues. As an employer, reviews are mixed, with some highlighting a positive work environment and others pointing to management or communication challenges.
Overall: MixedStrengths
- Advanced AI and machine learning capabilities for image analysis.
- High precision and accuracy in pathology quantification.
- Valuable for research and drug development.
- Good customer support and responsiveness (mentioned in some product reviews).
- Positive work culture and good colleagues (mentioned in some employer reviews).
- Comprehensive suite of tools for digital pathology workflows.
Limitations
- Steep learning curve for new users.
- Software can be resource-intensive, leading to performance issues.
- Pricing can be a barrier for smaller organizations.
- Occasional bugs or glitches reported.
- Mixed feedback on management and internal communication (employer reviews).
- Limited online community or user forums for support.
Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT News (general industry sentiment), Reddit
Last updated: 2026-08-06
Videos
News, demos, and interviews about Visiopharm.
Videos load interactively. If none appear, search YouTube for Visiopharm →
Press & Coverage
Frequently Asked Questions
Related Companies
Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]
Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]
Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]
Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]
Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]
SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]